IL6 and colorectal cancer: More research into the optimal combination therapy for colorectal cancer is desirable, but additional efforts are needed to define the features of radioresistant cellular subpopulations in depth, such as the presence of cancer stem cells and the secretion of other pro-inflammatory molecules frequently associated with SASP (e.g., IL-6, TNF-α).